Rising Biosciences Inc (RBII)

[Daley~Mail]

Rising BioSciences seeks to fulfill a yet-to-be-met market demand with a first-to-market approach so that patients across the U.S. get the treatment they so desperately need without falling subject to the dangers of opiates, whose long-term effects can include liver damage, dependence / addiction, and brain damage due to hypoxia, resulting from respiratory depression, among other complications.